Crystal structure of engineered CYS-CYS fab dimer VL-108 (LC33)
Domain Annotation: ECOD Classification ECOD Database Homepage
| Chains | Family Name | Domain Identifier | Architecture | Possible Homology | Homology | Topology | Family | Provenance Source (Version) |
|---|---|---|---|---|---|---|---|---|
| D [auth L] | Ribosomal_L2 | e7t98L1 | A: beta barrels | X: RNase A-like | H: Cytochrome P450 | T: Cytochrome P450 | F: Ribosomal_L2 | ECOD (v294.2) |
| B | Ribosomal_L2 | e7t98B1 | A: beta barrels | X: RNase A-like | H: Cytochrome P450 | T: Cytochrome P450 | F: Ribosomal_L2 | ECOD (v294.2) |
| C [auth H] | Ribosomal_L2 | e7t98H1 | A: beta barrels | X: RNase A-like | H: Cytochrome P450 | T: Cytochrome P450 | F: Ribosomal_L2 | ECOD (v294.2) |
| A | Ribosomal_L2 | e7t98A1 | A: beta barrels | X: RNase A-like | H: Cytochrome P450 | T: Cytochrome P450 | F: Ribosomal_L2 | ECOD (v294.2) |
Domain Annotation: CATH CATH Database Homepage
| Chain | Domain | Class | Architecture | Topology | Homology | Provenance Source (Version) |
|---|---|---|---|---|---|---|
| D [auth L] | 2.60.40.10 | Mainly Beta | Sandwich | Immunoglobulin-like | Immunoglobulins | CATH (utative) |
| B | 2.60.40.10 | Mainly Beta | Sandwich | Immunoglobulin-like | Immunoglobulins | CATH (utative) |
| C [auth H] | 2.60.40.10 | Mainly Beta | Sandwich | Immunoglobulin-like | Immunoglobulins | CATH (utative) |
| A | 2.60.40.10 | Mainly Beta | Sandwich | Immunoglobulin-like | Immunoglobulins | CATH (utative) |
SAbDab Antibody Annotation SAbDab Database Homepage
| Chain | Chain Class | Chain Subclass | Chain Type | Antigen Name(s) | Provenance Source |
|---|---|---|---|---|---|
| B, D [auth L] | Light Chain | IGKV1 | Kappa | - | SAbDab (2026-05-15) |
| A, C [auth H] | Heavy Chain | IGHV3 | - | - | SAbDab (2026-05-15) |
Thera-SAbDab Antibody Annotation Thera-SAbDab Database Homepage
| Chain | Name | Target | Provenance Source |
|---|---|---|---|
| B, D [auth L] | Trastuzumab | ERBB2/CD340/HER2, SIRPA, TNFRSF9/CD137/4-1BB, CD3E | Therapeutic SAbDab (2026-05-15) |
| A, C [auth H] | Timigutuzumab | ERBB2/CD340/HER2, CD3E, TNFRSF9/CD137/4-1BB, SIRPA | Therapeutic SAbDab (2026-05-15) |














